369 related articles for article (PubMed ID: 7628020)
1. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer.
de Wind N; Dekker M; Berns A; Radman M; te Riele H
Cell; 1995 Jul; 82(2):321-30. PubMed ID: 7628020
[TBL] [Abstract][Full Text] [Related]
2. HNPCC-like cancer predisposition in mice through simultaneous loss of Msh3 and Msh6 mismatch-repair protein functions.
de Wind N; Dekker M; Claij N; Jansen L; van Klink Y; Radman M; Riggins G; van der Valk M; van't Wout K; te Riele H
Nat Genet; 1999 Nov; 23(3):359-62. PubMed ID: 10545954
[TBL] [Abstract][Full Text] [Related]
3. Methylation tolerance in mismatch repair proficient cells with low MSH2 protein level.
Claij N; Te Riele H
Oncogene; 2002 Apr; 21(18):2873-9. PubMed ID: 11973647
[TBL] [Abstract][Full Text] [Related]
4. Candidate mutator genes in mismatch repair-deficient thymic lymphomas: no evidence of mutations in the DNA polymerase delta gene.
Campbell MR; Thang TY; Jirik FR; Andrew SE
Carcinogenesis; 2000 Dec; 21(12):2281-5. PubMed ID: 11133819
[TBL] [Abstract][Full Text] [Related]
5. DNA mismatch repair deficiency stimulates N-ethyl-N-nitrosourea-induced mutagenesis and lymphomagenesis.
Claij N; van der Wal A; Dekker M; Jansen L; te Riele H
Cancer Res; 2003 May; 63(9):2062-6. PubMed ID: 12727820
[TBL] [Abstract][Full Text] [Related]
6. Mutator phenotype in Msh2-deficient murine embryonic fibroblasts.
Reitmair AH; Risley R; Bristow RG; Wilson T; Ganesh A; Jang A; Peacock J; Benchimol S; Hill RP; Mak TW; Fishel R; Meuth M
Cancer Res; 1997 Sep; 57(17):3765-71. PubMed ID: 9288785
[TBL] [Abstract][Full Text] [Related]
7. Role for mismatch repair proteins Msh2, Mlh1, and Pms2 in immunoglobulin class switching shown by sequence analysis of recombination junctions.
Schrader CE; Vardo J; Stavnezer J
J Exp Med; 2002 Feb; 195(3):367-73. PubMed ID: 11828012
[TBL] [Abstract][Full Text] [Related]
8. Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis.
Baker SM; Bronner CE; Zhang L; Plug AW; Robatzek M; Warren G; Elliott EA; Yu J; Ashley T; Arnheim N; Flavell RA; Liskay RM
Cell; 1995 Jul; 82(2):309-19. PubMed ID: 7628019
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents.
Bodo S; Colas C; Buhard O; Collura A; Tinat J; Lavoine N; Guilloux A; Chalastanis A; Lafitte P; Coulet F; Buisine MP; Ilencikova D; Ruiz-Ponte C; Kinzel M; Grandjouan S; Brems H; Lejeune S; Blanché H; Wang Q; Caron O; Cabaret O; Svrcek M; Vidaud D; Parfait B; Verloes A; Knappe UJ; Soubrier F; Mortemousque I; Leis A; Auclair-Perrossier J; Frébourg T; Fléjou JF; Entz-Werle N; Leclerc J; Malka D; Cohen-Haguenauer O; Goldberg Y; Gerdes AM; Fedhila F; Mathieu-Dramard M; Hamelin R; Wafaa B; Gauthier-Villars M; Bourdeaut F; Sheridan E; Vasen H; Brugières L; Wimmer K; Muleris M; Duval A;
Gastroenterology; 2015 Oct; 149(4):1017-29.e3. PubMed ID: 26116798
[TBL] [Abstract][Full Text] [Related]
10. 1,2-Dimethylhydrazine-induced colon carcinoma and lymphoma in msh2(-/-) mice.
Colussi C; Fiumicino S; Giuliani A; Rosini S; Musiani P; Macrí C; Potten CS; Crescenzi M; Bignami M
J Natl Cancer Inst; 2001 Oct; 93(20):1534-40. PubMed ID: 11604476
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of mouse embryonic stem cells bearing Msh3 and Msh2 single and compound mutations.
Abuin A; Zhang H; Bradley A
Mol Cell Biol; 2000 Jan; 20(1):149-57. PubMed ID: 10594017
[TBL] [Abstract][Full Text] [Related]
12. Role of MUTYH and MSH2 in the control of oxidative DNA damage, genetic instability, and tumorigenesis.
Russo MT; De Luca G; Casorelli I; Degan P; Molatore S; Barone F; Mazzei F; Pannellini T; Musiani P; Bignami M
Cancer Res; 2009 May; 69(10):4372-9. PubMed ID: 19435918
[TBL] [Abstract][Full Text] [Related]
13. Deregulation of homologous recombination DNA repair in alkylating agent-treated stem cell clones: a possible role in the aetiology of chemotherapy-induced leukaemia.
Worrillow LJ; Allan JM
Oncogene; 2006 Mar; 25(12):1709-20. PubMed ID: 16278672
[TBL] [Abstract][Full Text] [Related]
14. Mutator phenotypes of yeast strains heterozygous for mutations in the MSH2 gene.
Drotschmann K; Clark AB; Tran HT; Resnick MA; Gordenin DA; Kunkel TA
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2970-5. PubMed ID: 10077621
[TBL] [Abstract][Full Text] [Related]
15. Saccharomyces cerevisiae MSH2-MSH3 and MSH2-MSH6 complexes display distinct requirements for DNA binding domain I in mismatch recognition.
Lee SD; Surtees JA; Alani E
J Mol Biol; 2007 Feb; 366(1):53-66. PubMed ID: 17157869
[TBL] [Abstract][Full Text] [Related]
16. Msh2 deficiency does not contribute to cisplatin resistance in mouse embryonic stem cells.
Claij N; te Riele H
Oncogene; 2004 Jan; 23(1):260-6. PubMed ID: 14712231
[TBL] [Abstract][Full Text] [Related]
17. Mouse models for hereditary nonpolyposis colorectal cancer.
de Wind N; Dekker M; van Rossum A; van der Valk M; te Riele H
Cancer Res; 1998 Jan; 58(2):248-55. PubMed ID: 9443401
[TBL] [Abstract][Full Text] [Related]
18. Analysis of yeast MSH2-MSH6 suggests that the initiation of mismatch repair can be separated into discrete steps.
Bowers J; Tran PT; Liskay RM; Alani E
J Mol Biol; 2000 Sep; 302(2):327-38. PubMed ID: 10970737
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the lack of mismatch-repair directed antirecombination during mouse meiosis.
Qin J; Baker S; Te Riele H; Liskay RM; Arnheim N
J Hered; 2002; 93(3):201-5. PubMed ID: 12195036
[TBL] [Abstract][Full Text] [Related]
20. Homologous recombination rescues mismatch-repair-dependent cytotoxicity of S(N)1-type methylating agents in S. cerevisiae.
Cejka P; Mojas N; Gillet L; Schär P; Jiricny J
Curr Biol; 2005 Aug; 15(15):1395-400. PubMed ID: 16085492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
